Why Diversity in Clinical Research must be Non-negotiable
Livia Ng, Founder and CEO of Neuroute explains the significance of diversity in clinical research and why it is a non-negotiable for science, for medicine…
Livia Ng, Founder and CEO of Neuroute explains the significance of diversity in clinical research and why it is a non-negotiable for science, for medicine…
European and US pharma companies have welcomed the EMA’s new clinical trials information system (CTIS), according to an Arriello survey. Arriello’s Kieran O’Donnell and Nicola…
It is no secret that Pharma (still) has a major diversity problem. Not only on their own senior leadership teams but also in their clinical…
Most life sciences Regulatory teams still think and work in terms of documents, paragraphs and sentences when putting together collateral for marketing authorisation and variations…
The last 300 years have seen phenomenal evolution in our understanding of, and approach to managing human health and wellbeing. It’s fair to say that…
Released this July, the UK Government’s Women’s Health Strategy aimed to address a very complex problem – gender inequality across the healthcare sector. Whilst the…
Globally, researchers have long since been working on various aspects of medicine and clinical trials are a core part of developing medicinal and health development…
Richard Craven, CliniSys UK and Ireland Managing Director, considers some of the big developments in pathology and how technology will help laboratories to confront current…
Successful pharma companies are adapting commercialisation strategies to align with transformation in healthcare delivery. Vintura’s Richard Ogborne and Chris Reynolds provide practical guidance as to…
One definition of patient-centricity is “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best…